Cite
HARVARD Citation
O'Donoghue, M. et al. (2018). Lipoprotein(a), PCSK9 Inhibition and cardiovascular risk: Insights from the Fourier trial. Atherosclerosis. pp. e9-e10. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
O'Donoghue, M. et al. (2018). Lipoprotein(a), PCSK9 Inhibition and cardiovascular risk: Insights from the Fourier trial. Atherosclerosis. pp. e9-e10. [Online].